SCHEDULE 13G: BlackRock Discloses 5.4% Passive Stake in Elevation Oncology, Inc.
Ownership Disclosure
BlackRock, Inc. has filed a Schedule 13G, reporting a passive beneficial ownership of 5.4% of Elevation Oncology, Inc.'s common stock as of December 31, 2024.
Summary
- BlackRock, Inc. reported beneficial ownership of 3,163,180 shares of Elevation Oncology, Inc. common stock.
- This ownership represents 5.4% of the total outstanding common stock of Elevation Oncology, Inc.
- BlackRock holds sole voting power over 3,134,100 shares and sole dispositive power over 3,163,180 shares.
- The filing indicates that the securities were acquired and are held in the ordinary course of business, not for the purpose of changing or influencing control of the issuer.
- The filing was made under Rule 13d-1(b), indicating BlackRock is a qualified institutional investor holding the shares passively.
- Several BlackRock subsidiaries, including BlackRock Advisors, LLC and BlackRock Fund Advisors, are identified as entities that may beneficially own shares.
Sentiment
Score: 5
Explanation: Neutral. This is a factual disclosure of an ownership stake by a large institutional investor, with no explicit positive or negative operational implications for the issuer within the document itself.
Future Outlook
NA
Industry Context
This filing reflects a standard disclosure by a major institutional asset manager, BlackRock, Inc., regarding its passive investment holdings in a publicly traded company, Elevation Oncology, Inc. Such disclosures are routine for large investment firms that cross significant ownership thresholds, providing transparency to the market about substantial shareholder positions.
Stakeholder Impact
- Shareholders: Provides transparency regarding a significant institutional holder's stake, which can influence market perception and liquidity.
- Market Participants: Informs the broader market of a major institutional investor's position in Elevation Oncology, Inc.
Key Dates
| Date | Description |
|---|---|
| 12/31/2024 | Date of event which requires filing of this statement (reporting period end date). |
| 01/21/2025 | Date of execution for the Power of Attorney document. |
| 02/04/2025 | Date of filing of the Schedule 13G statement. |
Keywords
BlackRock, Elevation Oncology, Schedule 13G, Institutional Ownership, Common Stock, Passive Investment, SEC Filing, Beneficial Ownership, Asset Management
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.